Literature DB >> 22017335

Mutation analysis of the CYP21A2 gene in the Iranian population.

Bahareh Rabbani1, Nejat Mahdieh, Mohammad Tahgi Haghi Ashtiani, Bagher Larijani, Mohammad Taghi Akbari, Maria New, Alan Parsa, Jan P Schouten, Ali Rabbani.   

Abstract

BACKGROUND: Defects in the CYP21A2 gene cause steroid 21-hydroxylase deficiency, which is the most frequent cause of congenital adrenal hyperplasia. Forty four affected families were investigated to identify the mutation spectrum of the CYP21A2 gene.
METHODS: Families were subjected to clinical, biochemical, and molecular analyses. Allele-specific polymerase chain reaction amplification was used for eight common mutations followed by dosage analysis to exclude CYP21A2 deletions.
RESULTS: The most frequent mutations detected were gene deletions and chimera (31.8%). Other mutation frequencies were as follows: Q318X, 15.9%; I2G, 14.8%; I172N, 5.8%; gene duplication, 5.7%; R356W, 8%; and E6 cluster mutations, 2.3%. Direct sequencing of the CYP21A2 gene revealed R316X, P453S, c.484insT, and a change at the start codon. Different modules carried by patients were classified into five different haplotypes. The genotype phenotype correlation (positive predictive value) for group null, A, B, and C were 92.3%, 85.7%, 100%, and 0, respectively.
CONCLUSIONS: Methods used will be helpful for carrier detection and antenatal diagnosis, especially with inclusion of the multiplex ligation probe dependent amplification technique, which is easier for routine tests in comparison with other methods. Mutation frequencies indicate that Iranians are possible descendants of Asians and Europeans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017335      PMCID: PMC3277924          DOI: 10.1089/gtmb.2011.0099

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  45 in total

1.  Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency.

Authors:  H H Lee; J G Chang; C H Tsai; F J Tsai; H T Chao; B Chung
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

Review 2.  Newborn screening for congenital adrenal hyperplasia.

Authors:  B L Therrell
Journal:  Endocrinol Metab Clin North Am       Date:  2001-03       Impact factor: 4.741

3.  Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes.

Authors:  Paul F J Koppens; Theo Hoogenboezem; Herman J Degenhart
Journal:  Hum Genet       Date:  2002-09-07       Impact factor: 4.132

4.  How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency.

Authors:  D L'Allemand; V Tardy; A Grüters; D Schnabel; H Krude; Y Morel
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 5.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P C White; P W Speiser
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

6.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  Transcriptional regulatory elements of the human gene for cytochrome P450c21 (steroid 21-hydroxylase) lie within intron 35 of the linked C4B gene.

Authors:  S D Wijesuriya; G Zhang; A Dardis; W L Miller
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

8.  A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency.

Authors:  T Tukel; O Uyguner; J Q Wei; M Yuksel-Apak; N Saka; D X Song; H Kayserili; F Bas; H Gunoz; R C Wilson; M I New; B Wollnik
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

Review 9.  Statistical study of 35delG mutation of GJB2 gene: a meta-analysis of carrier frequency.

Authors:  Nejat Mahdieh; Bahareh Rabbani
Journal:  Int J Audiol       Date:  2009       Impact factor: 2.117

10.  Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.

Authors:  Maher Kharrat; Véronique Tardy; Ridha M'Rad; Faouzi Maazoul; Lamia Ben Jemaa; Mohamed Refaï; Yves Morel; Habiba Chaabouni
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

View more
  10 in total

1.  Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Maria I New; Moolamannil Abraham; Brian Gonzalez; Miroslav Dumic; Maryam Razzaghy-Azar; David Chitayat; Li Sun; Mone Zaidi; Robert C Wilson; Tony Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

Review 2.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

3.  A Case of Salt-Wasting Congenital Adrenal Hyperplasia with Triple Homozygous Mutation: Review of Literature.

Authors:  Maria Laura Iezzi; Gaia Varriale; Luca Zagaroli; Stefania Lasorella; Marco Greco; Giulia Iapadre; Alberto Verrotti
Journal:  J Pediatr Genet       Date:  2020-03-09

4.  Clinical profile and inheritance pattern of CYP21A2 gene mutations in patients with classical congenital adrenal hyperplasia from 10 families.

Authors:  Sarita Yadav; Shweta Birla; Eunice Marumudi; Arundhati Sharma; Rajesh Khadgawat; M L Khurana; A C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

5.  A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia. Molecular genetics report from Saudi Arabia.

Authors:  Sarar Mohamed; Suzan El-Kholy; Nasir Al-Juryyan; Abdulrahman M Al-Nemri; Khaled K Abu-Amero
Journal:  Saudi Med J       Date:  2015-01       Impact factor: 1.484

6.  p.Gln318X and p.Val281Leu as the Major Variants of CYP21A2 Gene in Children with Idiopathic Premature Pubarche.

Authors:  Mahdieh Soveizi; Nejat Mahdieh; Aria Setoodeh; Fatemeh Sayarifard; Farzaneh Abbasi; Himangshu S Bose; Bahareh Rabbani; Ali Rabbani
Journal:  Int J Endocrinol       Date:  2020-05-15       Impact factor: 3.257

7.  An Iranian Congenital Adrenal Hypoplasia Patient with Elevated Testosterone in Infancy due to a Novel Pathogenic Frameshift Variant in NR0B1.

Authors:  Samira Kalayinia; Saeed Talebi; Mohammad Miryounesi; Peymaneh Sarkhail; Nejat Mahdieh
Journal:  Int J Endocrinol       Date:  2021-12-13       Impact factor: 3.257

8.  21-hydroxylase deficiency: newborn screening in iran?

Authors:  Nejat Mahdieh; Bahareh Rabbani; Ali Rabbani
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

9.  Mutation detection of CYP21A2 gene in nonclassical congenital adrenal hyperplasia patients with premature pubarche.

Authors:  Mahsa Kolahdouz; Mahin Hashemipour; Hossein Khanahmad; Bahareh Rabbani; Mansoor Salehi; Ali Rabbani; Arman Ansari; Mona Mobalegh Naseri
Journal:  Adv Biomed Res       Date:  2016-03-16

Review 10.  Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Mahsa Kolahdouz; Zahra Mohammadi; Parisa Kolahdouz; Masoud Tajamolian; Hossein Khanahmad
Journal:  Adv Biomed Res       Date:  2015-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.